Sage Journals: Discover world-class research

Retricted access

Research article

First published 2012-01

HER-3 Status by Immunohistochemistry in HER-2-Positive Metastatic Breast Cancer Patients Treated with Trastuzumab: Correlation with Clinical Outcome

Stefania Gori, Jennifer Foglietta, Maria Grazia Mameli [...]

Tumori Journal

Free access

Review article

First published 2016-9

Neratinib in HER-2-positive breast cancer: results to date and clinical usefulness

Arlene Chan

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2015-5

Lapatinib: An Oral Dual Tyrosine Kinase Inhibitor for HER-2-Positive Breast Cancer

Sagar D Sardesai, Anna Maria Storniolo

Women's Health

Free access

Research article

First published 2007-9

Docetaxel Plus Trastuzumab as Treatment for Her-2 Positive Metastatic Breast Cancer: Review of the Existing Evidence

Gaston Demonty

Women's Health

Free access

Research article

First published 2009-1

Circulating Tumor Cells in HER-2 Positive Metastatic Breast Cancer Patients Treated with Trastuzumab and Chemotherapy

Raquel A. Nunes, Xiaochun Li, Soonmo Peter Kang [...]

The International Journal of Biological Markers

Retricted access

Case report

First published 2015-8

The combination of weekly trastuzumab plus vinorelbine may be preferable regimen in HER-2 positive breast cancer patients with brain metastasis

Hasan Mutlu, Abdullah Büyükçelik

Journal of Oncology Pharmacy Practice

Open access

Case report

First published 2019

A Rare Case of Triple Positive Metachronous Breast Cancer

Hardik S. Chhatrala, John Khuu, Lara Zuberi

Journal of Investigative Medicine High Impact Case Reports

Free access

Review article

First published 2023-04-20

Efficacy and safety of antibody-drug conjugates in triple-negative and HER-2 positive breast cancer: A systematic review and meta-analysis of clinical trials

Fatima Afzal, Wajeeha Aiman, Hafsa Zahoor [...]

Breast Disease

Open access

Other

First published 2021

Educational Case: HER-2 Positive Breast Cancer

Julia Jennings, Jennifer L. Clark

Academic Pathology

Retricted access

Research article

First published 2021-4

Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

Deniz Tataroglu Ozyukseler, Mustafa Basak, Seval Ay [...]

Journal of Oncology Pharmacy Practice

Search results